The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study (Q37298079)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 June 2013

Language	Label	Description	Also known as
English	The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study	scientific article published on 26 June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

multicenter clinical trial

0 references

Duchenne muscular dystrophy

1 reference

based on heuristic

inferred from title

Craig M. McDonald

object named as

Craig M McDonald

1

0 references

author name string

Erik K Henricson

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

R Ted Abresch

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Julaine M Florence

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Michelle Eagle

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Eduard Gappmaier

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Allan M Glanzman

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PTC124-GD-007-DMD Study Group

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Robert Spiegel

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jay Barth

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Gary Elfring

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Allen Reha

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Stuart Peltz

13

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 June 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Muscle and Nerve

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

48

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

343-356

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Systemic administration of PRO051 in Duchenne's muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

A randomized study of alglucosidase alfa in late-onset Pompe's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

PTC124 targets genetic disorders caused by nonsense mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Longitudinal data analysis: an application to construction of a natural history profile of Duchenne muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

6 September 2017

Clinical investigation in duchenne dystrophy: 2. Determination of the ?power? of therapeutic trials based on the natural history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

28 September 2017

Profiles of neuromuscular diseases. Duchenne muscular dystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

26 June 2018

Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

26 June 2018

Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

Six-minute walk test in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

Profiles of neuromuscular diseases. Design of the protocol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824082

2 September 2018

North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23902

21 January 2018

Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial in Duchenne dystrophy. I. The design of the protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leisure-time physical activity among US adults. Results from the Third National Health and Nutrition Examination Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are surrogate markers adequate to assess cardiovascular disease drugs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of Duchenne muscular dystrophy: a caveat for therapeutic trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determining the minimal clinically important difference for the six-minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/MUS.23902

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37298079&oldid=2238827325"